GLP1R and stroke disorder: Overall, the safety profile of GLP-1 receptor agonists is favorable, and while they are associated with increases in HR, they have shown CV benefit with improvements in BP, lipids, CV death, non-fatal myocardial infarction, and non-fatal stroke.